Class Action Lawsuits Filed Against iRhythm Technologies Over Securities Fraud

Investors allege misrepresentation of heart monitor's capabilities, leading to inflated stock prices.

Several law firms have announced class action lawsuits against iRhythm Technologies, Inc. for alleged securities fraud.
The lawsuits claim iRhythm misrepresented the capabilities and approval status of its Zio AT heart monitor, leading to inflated stock prices.
The class period for the lawsuits is between January 11, 2022, and May 30, 2023.
Investors who purchased iRhythm stock during this period are encouraged to join the lawsuits.
The deadline to seek lead plaintiff status in the lawsuits is April 8, 2024.